Wolverine Asset Management LLC Immuno Gen, Inc. Put Options Transaction History

Wolverine Asset Management LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $45,195 - $64,058	-13,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $29,475 - $75,980	13,100 New	13,100 $66,000
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $12,675 - $19,800	-2,500 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	2,500	2,500 $17,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.